Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

LIFECORE BIOMEDICAL, INC. \DE\ Director's Dealing 2012

May 16, 2012

33431_dirs_2012-05-16_1cf22cde-52dc-4a88-882d-d2ff165f48cb.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LANDEC CORP \CA\ (LNDC)
CIK: 0001005286
Period of Report: 2012-02-15

Reporting Person: STEELE GARY T (Director, CEO and President)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2012-05-15 Common Stock M 100000 $6.13 Acquired 180800 Indirect
2012-05-15 Common Stock M 95048 $6.65 Disposed 85752 Indirect

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2012-05-15 NonQualified Stock Option $6.13 M 100000 Disposed 2012-05-19 Common Stock (100000) Direct

Footnotes

F1: Mr Steele surrendered to the Issuer the right to receive an aggregate of 95,048 shares of Common Stock. Mr Steele did not sell any Common Stock in connection with the foregoing exercise.